Gastrointestinal Cancer News

Michael A. Caligiuri, MD, has been inaugurated as the 2017-2018 president of the American Association for Cancer Research.

Adults who take low-dose aspirin over an extended period of time demonstrated lower mortality from many cancers, including breast cancer, prostate cancer and lung cancer, according to data presented at the American Association for Cancer Research Annual Meeting.

The number of prescriptions written for physician-aided deaths in Oregon has increased annually since it became the first state to enact the Death with Dignity Act in 1997, according to a retrospective cohort study published in JAMA Oncology.

Sexual and gender minorities diagnosed with cancer may encounter specific challenges, including discrimination and greater risks for anxiety and depression, according to an ASCO guideline published in Journal of Clinical Oncology.

Researchers associated long-term use of antibiotics in early to mid-adulthood with an increased risk for colorectal adenomas in a recent study.

Adults with certain disabilities are less likely to undergo recommended colorectal cancer screening compared with individuals without disabilities, according to the results of a 10-year study.

The FDA granted orphan drug designation to Yeliva for the treatment of cholangiocarcinoma, according to the drug’s manufacturer.

The rate of colon cancer screening remains high among patients receiving maintenance dialysis, despite American Society of Nephrology recommendations against routine cancer screening in this patient population because it does not improve survival.

The combination of trastuzumab plus lapatinib appeared clinically beneficial for patients with treatment-refractory HER-2–positive metastatic colorectal cancer, according to results of the phase 2 HERACLES trial presented at the American Association for Cancer Research Annual Meeting.

International and private sector collaboration, as well as the $1.8 billion in federal funding directed toward the NIH as part of the 21st Century Cures Act, are two major accomplishments of the national cancer moonshot initiative achieved in the past year, according to former Vice President Joe Biden.